28.1400.14% ( +0.040 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 25.05, within the reasonable range, cheaper than 34.36% of the time in the past 5 years, and the industry ranks 6/15, the industry Median 12.44.
25.05xP/E
HK$28.14Stock price
HK$1.12Earnings per share
25.05xP/E
Stock priceHK$28.14Earnings per shareHK$1.12
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 20.86x
- Typical range
- 12.21x–31.22x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.44x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.44x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
03759HKPHARMARON | 25.05x | 18.49% | HK$51.65B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
